Generating Effectiveness Mechanisms in RUBI (GEMs in RUBI)

Researchers at Seattle Children’s are looking for caregivers of children without autism spectrum disorder or challenging behaviors (e.g., aggression, destruction) to take part in a 30-minute online survey study and a one-time in-person EEG and cognitive assessment visit. The goal of this study is to study parent and child problem-solving and emotions in an intervention that includes parents.

Read More


WONDER_Logo The Washington Study of Outcomes, Neural Development, and Early Risk (WONDER) study, ran by Seattle Children’s Innovative Technologies Lab (SCITL), researches the development of the social brain over the first three years of life with an ultimate goal of studying developmental trajectories of infants born at risk for developmental delays. We are recruiting infants under the age of 6 months.

Read more


The L16HTHOUSE study is a Phase 2 clinical trial of arbaclofen in children with 16p11.2 deletion syndrome, a genetic condition associated with autism spectrum disorder (ASD) and other developmental challenges. The study aims to examine the safety, tolerability and efficacy of arbaclofen in improving speech, social function, cognition and motor skills in this population.
Read more


Seattle Children’s Research Institute in conjunction with 7 participating institutes from an Autism Centers of Excellence (ACE) network, is conducting a research study with participants with and without autism, ages 12-35. The purpose of this longitudinal study is to better understand autism spectrum disorders (ASD) in both males and females.

Read more